Eur Rev Med Pharmacol Sci 2020; 24 (5): 2557-2563

DOI: 10.26355/eurrev_202003_20523

DGCR8 promotes the metastasis in triple-negative breast cancer by epigenetically regulating TGF-β

C.-Y. Cui, Q.-W. Pan, M.-H. Wang, X. Ai, Y.-Z. Yan, Y. Tian, Y.-T. Jin, P. Tang, J. Jiang, Z.-X. Ren

Department of Breast, Thyroid and Hernia Surgery, Liaocheng People’s Hospital, Shandong, China. renzx09@126.com


OBJECTIVE: Breast cancer (BC) is one of the most ordinary fatal cancers. Recent studies have identified the vital role of genes in the development and progression of Tri-negative breast cancer (TNBC). In this research, DGCR8 was studied to identify how it functioned in the metastasis of TNBC.

PATIENTS AND METHODS: DGCR8 expression of tissues was detected by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) in 50 TNBC patients. Wound healing assay and transwell assay were used to observe the changes in the biological behaviors of TNBC cells through knockdown or overexpression of DGCR8. In addition, qRT-PCR and Western blot assay were performed to discover the potential target protein of DGCR8 in TNBC.

RESULTS: DGCR8 expression level in TNBC samples was higher than that of adjacent ones. Besides, the migration ability and invasion ability of TNBC cells were inhibited after DGCR8 was silenced, while they were promoted after DGCR8 was overexpressed. In addition, TGF-β was downregulated after silencing of DGCR8 in TNBC cells, while TGF-β was upregulated after overexpression of DGCR8 in TNBC cells. Furthermore, TGF-β was upregulated in TNBC tissues, which was positively associated with DGCR8.

CONCLUSIONS: Our study uncovers a new oncogene in TNBC and suggests that DGCR8 can enhance TNBC cell migration and invasion via targeting TGF-β, which provides a novel therapeutic target for TNBC patients.

Free PDF Download

To cite this article

C.-Y. Cui, Q.-W. Pan, M.-H. Wang, X. Ai, Y.-Z. Yan, Y. Tian, Y.-T. Jin, P. Tang, J. Jiang, Z.-X. Ren
DGCR8 promotes the metastasis in triple-negative breast cancer by epigenetically regulating TGF-β

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 5
Pages: 2557-2563
DOI: 10.26355/eurrev_202003_20523